000 01336 a2200325 4500
005 20250514235904.0
264 0 _c20051219
008 200512s 0 0 eng d
022 _a0742-3071
024 7 _a10.1111/j.1464-5491.2005.01632.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCarter, A M
245 0 0 _aMetformin reduces C-reactive protein but not complement factor C3 in overweight patients with Type 2 diabetes mellitus.
_h[electronic resource]
260 _bDiabetic medicine : a journal of the British Diabetic Association
_cSep 2005
300 _a1282-4 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aC-Reactive Protein
_xanalysis
650 0 4 _aComplement C3
_xanalysis
650 0 4 _aDiabetes Mellitus, Type 2
_xblood
650 0 4 _aDouble-Blind Method
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xtherapeutic use
650 0 4 _aMetformin
_xtherapeutic use
650 0 4 _aObesity
_xblood
700 1 _aBennett, C E
700 1 _aBostock, J A
700 1 _aGrant, P J
773 0 _tDiabetic medicine : a journal of the British Diabetic Association
_gvol. 22
_gno. 9
_gp. 1282-4
856 4 0 _uhttps://doi.org/10.1111/j.1464-5491.2005.01632.x
_zAvailable from publisher's website
999 _c15746093
_d15746093